Diss. (sammanfattning) Umeå : Umeå universitet, 2008. / Härtill 4 uppsatser.

The overall objective of this study was to identify novel proteins of the nuclear matrix in order to contribute to a better understanding of nuclear structure and organization. To accomplish this, a monoclonal antibody specific for the nuclear matrix was used to screen a human λgt11 expression library. Several cDNAs were isolated, cloned, sequenced, and shown to represent NuMA, the nuclear mitotic spindle apparatus protein. Further characterization of the gene and RNA was undertaken in an effort to obtain information about NuMA. The NuMA gene was present at a single site on human chromosome 11q13. Northern and PCR analysis of NuMA mRNA showed a major 7.2 kb transcript and minor forms of 8.0 and 3.0 kb. The minor forms were shown to be alternatively spliced although their functional significance is not yet understood. Immunofluorescence microscopy demonstrated that NuMA oscillates between the nucleus and the microtubule spindle apparatus during the mitotic cell cycle. NuMA appeared as a 200-275 kDa protein detectable in all mammalian cells except human neutrophils. To determine whether NuMA's changes in intracellular distribution correlated with post-translational modifications, the protein's phosphorylation state was examined through the cell cycle using highly synchronized cells. NuMA was a phosphoprotein in interphase and underwent additional phosphorylation events in mitosis. The mitotic phosphorylation events occurred with similar timing to lamin B (G2/M transition) and were concomitant with NuMA's release from the nucleus and its association with the mitotic spindle. However, the mitotic phosphorylation occurred in the absence of spindle formation. Dephosphorylation of NuMA did not correlate with reassociation with the nuclear matrix but occurred in two distinct steps after nuclear reformation. Based on the timing of these events, phosphorylation may playa role in nuclear processes. In conclusion, the work in this dissertation identified NuMA, a nuclear matrix protein and showed that it is phosphorylated during the cell cycle and may be important for nuclear events such as nuclear organization, transcription, or initiation of DNA replication at G1/S.

CARACTERISATION IN VITRO ET IN VIVO DE NOUVEAUX AGENTS PYRROLO-PYRIMIDINE CIBLANT LES MICROTUBULES POUR LE TRAITEMENT DES CANCERSEn dépit de l’émergence des thérapies ciblées et de l’immunothérapie, la chimiothérapie reste un gold-standard pour le traitement de nombreux cancers. Parmi les agents chimiothérapeutiques conventionnels, les poisons du fuseau interférant avec la dynamique des microtubules (taxanes, vinca-alcaloïdes) sont très largement utilisés. Cependant, leurs nombreux effets indésirables et l’émergence de chimiorésistance limitent leur efficacité et soulignent la nécessité d’identifier de nouveaux inhibiteurs de la tubuline.Notre équipe a réalisé un criblage cellulaire à haut-débit sur plus de 7500 molécules chimiques et identifié une famille de composés pyrrolo-pyrimidine, active sur les formes de cancer pulmonaire résistantes à l’apoptose et aux thérapies ciblées. Notre objectif était de caractériser in vitro et in vivo 15 molécules de cette famille afin d’identifier à terme un potentiel candidat-médicament pour le traitement des cancers résistants.Des essais préliminaires de cytotoxicité et d’apoptose sur différentes lignées cancéreuses pulmonaires ont permis de sélectionner, parmi les 15 composés pyrrolo-pyrimidine, 2 molécules prometteuses : PP-2 et PP-13. PP-2 et PP-13 ont des effets cytotoxiques sur de nombreuses lignées cancéreuses humaines, incluant les lignées résistantes aux thérapies ciblées. En perturbant l’organisation et la dynamique des microtubules, PP-2 et PP-13 induisent le blocage transitoire des cellules en prométaphase puis aboutissent aux phénomènes de catastrophe mitotique, de glissement mitotique ou de division asymétrique. Des études mécanistiques avancées montrent que PP-2 et PP-13 sont des agents poisons du fuseau et entrent en compétition avec la colchicine pour la liaison sur la tubuline. Contrairement aux antimitotiques conventionnels, PP-2 et PP-13 ne sont pas sensibles aux mécanismes de chimiorésistance par surexpression de pompes d’efflux. De plus, à l’IC50, ces 2 composés n’affectent pas le réseau microtubulaire des cellules à l’interphase suggérant un effet toxique (et principalement neurotoxique) moindre. La molécule PP-13 semble être la molécule anticancéreuse la plus prometteuse en raison de son IC50 10 fois inférieure à celle de PP-2 dans les différentes lignées cancéreuses étudiées et d’une affinité pour la tubuline 2 fois plus élevée. In vivo, PP-13 réduit significativement la croissance tumorale et étastatique. L’ensemble de ces résultats suggère que PP-13 pourrait être une alternative intéressante pour le traitement de nombreux cancers y compris des cancers chimiorésistants. / CHARACTERIZATION OF NEW MICROTUBULE-TARGETING AGENTS WITH A PYRROLO-PYRIMIDINE STRUCTURE FOR THE TREATMENT OF CANCERSDespite the emergence of targeted therapies and immunotherapy, chemotherapy remains a gold-standard for the treatment of numerous malignancies. Spindle poisons that interfere with microtubule dynamics (taxanes, vinca alkaloids) are commonly used in chemotherapy drug combinations. However, their troublesome side effects and the emergence of resistance highlight the need for identifying alternative agents. Thanks to a high throughput cell-based assay, we screened agents able to restore apoptosis in apoptosis-resistant lung cancer cells. We selected 15 molecules belonging to the pyrrolopyrimidine family and investigated their anti-cancer effects in vitro and in vivo. Our aim was to identify a potential drug-candidate for the treatment of resistant cancers.From cytotoxicity and apoptosis preliminary assays, we selected the 2 most promising molecules (PP-2, PP-13) among the 15 pyrrolopyrimidine compounds. PP-2 and PP-13 exert cytotoxic effects on a large panel of human cancer cell lines, including targeted therapy-resistant cell lines. By interfering with mitotic spindle organization and microtubule dynamics, PP-2 and PP-13 impair the congression of the chromosomes, promote spindle assembly checkpoint-dependent mitotic blockade and finally lead to asymmetric division, mitotic slippage and direct apoptotic death. PP-2 and PP-13 directly target tubulin and compete with colchicine for the binding to tubulin. Unlike conventional antimitotic agents, PP-2 and PP-13 are not sensitive to chemoresistance mechanisms involving the overexpression of efflux pumps. Moreover, at IC50, these two compounds do not affect the microtubule network during interphase suggesting a less toxic (mainly neurotoxic) effect. Among these two compounds, the PP-13 molecule appears to be the most interesting anti-cancer molecule because of its IC50 10-fold lower than PP-2 and its 2-fold higher affinity for tubulin. In vivo, PP-13 significantly reduces tumor and metastasis growth. All these results suggest that PP-13 might be a potential alternative for the treatment of many cancers including chemoresistant cancers.

Os mecanismos etiopatogênicos da infertilidade relacionada à endometriose não estão bem elucidados, especialmente em mulheres com estágios iniciais da doença (mínima e leve), em que não são observadas alterações anatômicas expressivas na cavidade pélvica. Questionamos a possibilidade de haver alterações no microambiente peritoneal de mulheres inférteis com endometriose que poderiam afetar a aquisição da competência oocitária e dessa forma, comprometer a fertilidade natural dessas mulheres. Para ser competente, o oócito precisa estar maduro e ter um fuso meiótico morfologicamente normal e funcional, garantindo a fidelidade da segregação cromossômica durante as divisões da meiose. Nesse sentido, o objetivo do presente estudo foi comparar o potencial impacto de diferentes concentrações (1% e 10%) de fluido peritoneal (FP) de mulheres férteis sem endometriose e mulheres inférteis com endometriose mínima e leve (EI/II) sobre a integridade do fuso celular e alinhamento cromossômico de oócitos bovinos maturados in vitro. Realizou-se um estudo experimental, onde amostras de FP foram obtidas de 12 mulheres (6 mulheres férteis sem endometriose e 6 mulheres inférteis com endometriose mínima e leve) submetidas a videolaparoscopia, respectivamente, para realização de laqueadura tubária e investigação de infertilidade. Oócitos bovinos imaturos foram submetidos a maturação in vitro (MIV) na ausência de FP, na presença de 1% e 10% de FP de mulheres férteis sem endometriose e na presença de 1% e 10% de FP de mulheres inférteis com EI/II. Foram realizados 6 experimentos de MIV e cada amostra de FP foi utilizada em apenas um experimento. Os oócitos foram fixados, marcados por imunofluorescência e então analisados por microscopia confocal. A porcentagem de oócitos meioticamente normais foi significantemente maior nos oócitos submetidos a MIV na ausência de FP (88.46%) e na presença de 1% (78.57%) e 10% (84.62%) de FP de mulheres férteis sem endometriose do que aqueles oócitos submetidos a MIV na presença de 1% (62.50%) e 10% (56.25%) de FP de mulheres inférteis com EI/II. Além disso, no grupo endometriose, a porcentagem de oócitos meioticamente normais foi significantemente maior nos oócitos submetidos a MIV na presença de 1% (62.50%) do que na presença de 10% (56.25%) de FP, sugerindo um efeito dose-dependente do FP de mulheres com endometriose na ocorrência de danos meióticos oocitários. Demonstrou-se que o FP de mulheres inférteis com EI/II comprometeu a maturação nuclear oocitária durante a MIV, de modo dosedependente, promovendo anormalidades meióticas em oócitos em metáfase II. Nossos resultados contribuem para a compreensão dos mecanismos etiopatogênicos da infertilidade relacionada à EI/II e abrem perspectivas para o estudo de novas abordagens terapêuticas visando melhorar a fertilidade natural destas pacientes. / The etiopathogenic mechanisms of endometriosis-related infertility are not well elucidated, especially in women with early stages of the disease (minimal and mild endometriosis), where significant anatomical abnormalities in the pelvic cavity are not observed. We question if alterations in the peritoneal microenvironment of infertile women with endometriosis might affect oocyte competence acquisition and in this way, compromise the natural fertility in these women. To be competent, the oocyte must be mature and have a morphologically normal and functional meiotic spindle, which ensure the fidelity of chromosome segregation during the divisions of meiosis. Thus, the aim of the present study was to compare the potencial impact of different concentrations (1% and 10%) of peritoneal fluid (PF) from fertile women without endometriosis and infertile women with minimal and mild endometriosis (EI/II) on spindle integrity and chromosomes alignment of bovine oocytes in vitro matured (IVM). We performed an experimental study, where PF samples were obtained from 12 women (six fertile women without endometriosis and six infertile women with minimal and mild endometriosis) submitted to laparoscopy, respectively for tubal ligation and investigation of infertility. Immature bovine oocytes were submitted to IVM in the absence of PF, in the presence of 1% and 10% PF from fertile women without endometriosis and in the presence of 1% and 10% PF from infertile women with EI/II. We performed 6 experiments of IVM and each PF sample was used in only one experiment. The oocytes were fixed, immunofluorescence staining and then, analyzed by confocal microscopy. The percentage of meiotically normal oocytes was significantly higher for oocytes that underwent IVM in the absence of PF (88.46%) and in the presence of 1% (78.57%) and 10% (84.62%) PF from fertile women without endometriosis than for oocytes that underwent IVM in the presence of 1% (62.50%) and 10% (56.25%) PF from infertile women with EI/II. Furthermore, in the endometriosis group, the percentage of meiotically normal oocytes was significantly higher for oocytes that underwent IVM in the presence of 1% (62.50%) than in the presence of 10% (56.25%) PF, suggesting a dose-dependent effect of PF from women with endometriosis on the occurrence of meiotic oocyte damage. The study have demonstrated that PF from infertile women with EI/II compromised the oocyte nuclear maturation during the IVM, in a dosedependent manner, promoting meiotic abnormalities in metaphase II oocytes. Our results contribute to a better understanding of the etiopathogenic mechanisms of infertility related to EI/II and open perspectives in the design of new therapeutic approaches to improve the natural fertility of these infertile women

Os mecanismos envolvidos na etiopatogênese da infertilidade em pacientes com endometriose não foram totalmente elucidados. A infertilidade apresentada por pacientes com as formas moderada e grave (estadios III e IV, respectivamente) seria, parcialmente, decorrente de alterações anatômicas pélvicas associadas à endometriose. Entretanto, há evidências de que lesões sutis ou implantes endometrióticos em estágios iniciais (estágio mínimo e leve) também poderiam contribuir com a etiopatogênese da infertilidade. Uma pior qualidade oocitária pode estar envolvida nas menores taxas de implantação após fertilização in vitro encontradas nessas pacientes. Questionamos a possibilidade de haver alterações no microambiente folicular de pacientes inférteis com endometriose, as quais poderiam afetar a aquisição de competência oocitária e, consequentemente, comprometer a fertilidade natural e os resultados dos tratamentos de reprodução assistida em mulheres com esta doença. Sabe-se que, para ser competente e poder ser fertilizado, o oócito precisa estar maduro e ter um fuso morfologicamente funcional, que garanta a fidelidade da segregação cromossômica durante a meiose. Dessa forma, o objetivo deste estudo foi avaliar o potencial impacto de diferentes concentrações de fluido folicular (FF) de mulheres inférteis com e sem endometriose leve sobre a integridade do fuso, alinhamento cromossômico e organização dos microfilamentos de actina de oócitos bovinos maturados in vitro. Realizou-se um estudo experimental, onde amostras de fluido follicular foram consecutivamente obtidas de 22 pacientes inférteis (11 com endometriose leve e 11 com infertilidade por fator tubário e/ou masculino) submetidas à estimulação ovariana para injeção intracitoplasmática de espermatozóide. Oócitos bovinos imaturos foram submetidos à maturação in vitro (MIV) sem adição de fluido follicular (sem fluido) e com 4 concentrações (1%, 5%, 10%, e 15%) de duas amostras de fluido folicular (uma de paciente com endometriose e outra de paciente sem endometriose). Foram realizadas 11 MIVs e cada amostra de fluido follicular foi usada apenas uma vez. Os oócitos foram fixados, marcados por imunofluorescência para visualização morfológica de microtúbulos, cromatina e microfilamentos de actina e, então, analisados por microscopia confocal. A porcentagem de anormalidade de oócitos em MII (fuso normal e cromossomos desalinhados, fuso anormal e cromossomos desalinhados, fuso anormal e cromossomos alinhados) foi significativamente maior naqueles maturados com FF de pacientes com endometriose (1%: 55,56%, 5%: 63,26%, 10%: 54,54%, 15%: 48,84%) quando comparados com oócitos maturados com FF de pacientes controles (1%: 19,15%, 5%: 23,44%, 10%: 25%, 15%: 23,81%) e oócitos maturados sem fluido (23,53%), sem haver diferença entre as concentrações testadas em cada grupo. Pode-se concluir que oócitos bovinos maturados in vitro na presença de FF de mulheres inférteis com endometriose leve têm maior freqüência de anormalidade meiótica. Estes dados sugerem que o FF de mulheres com endometriose pode comprometer a qualidade oocitária por promover danos ao fuso e/ou cromossomos / The mechanisms involved in the etiopathogenesis of infertility in patients with endometriosis have not been fully elucidated. The infertility presented by patients with moderate and severe disease (stages III and IV, respectively) would be partly due to anatomical pelvic changes associated with endometriosis. However, there are evidences that subtle lesions or endometriosis implants in the early stages (stages I and II) might also contribute to the etiophatogenesis of infertility. Impaired oocyte quality may be involved in lower implantation rates after in vitro fertilization in these patients. We question if alterations in the follicular microenvironment of infertile patients with endometriosis might affect oocyte competence acquisition and compromise the natural fertility and assisted reproduction treatment outcomes in women with this disease. It is known that to be competent and capable of fertilizing, the oocyte must be mature and have a morphologically functional spindle, which ensure the fidelity of chromosome segregation during meiosis. Thus, the aim of this study was to evaluate the potential impact of different concentrations of follicular fluid (FF) of infertile women with and without mild endometriosis on spindle integrity, chromosomes alignment and actin microfilaments organization of bovine oocytes in vitro matured. We performed an experimental study, where FF samples were consecutively obtained from 22 infertile patients (11 with mild endometriosis and 11 with tubal or male factors of infertility) submitted to ovarian stimulation for intracytoplasmic sperm injection. Immature bovine oocytes were submitted to in vitro maturation (IVM) without FF and with 4 concentrations (1%, 5%, 10%, and 15%) of 2 samples of FF (1 from a woman with endometriosis and one from a woman without endometriosis). We performed 11 IVM and each FF sample was used only once. The oocytes were then fixed, stained by immunofluorescence for morphological visualization of microtubules, chromatin and actin microfilaments, and then, analyzed by confocal microscopy. The percentage of abnormal MII oocytes was significantly higher for those matured with FF from patients with endometriosis (1%: 55.56%, 5%: 63.26%, 10%: 54.54%, 15%: 48.84%) when compared with oocytes matured with FF from patients without endometriosis (1%: 19.15%, 5%: 23.44%, 10%: 25%, 15%: 23.81%) and those matured without FF (23.53%), with no differences among the tested concentrations in each group. We can conclude that bovine oocytes matured in vitro in the presence of FF from infertile women with mild endometriosis have higher frequency of meiotic abnormalities. These data suggest that FF from women with endometriosis may compromise oocyte quality by promoting spindle and/or chromosomal damage

Introdução: Apesar de controverso, questiona-se um papel deletério da endometriose nos resultados de procedimentos de reprodução assistida, o que pode estar relacionado ao comprometimento da qualidade oocitária. Para que o oócito maduro esteja preparado para a fertilização, é necessário que o fuso meiótico mantenha a sua integridade e funcionabilidade. Objetivos: Comparar a presença e localização do fuso meiótico e o estágio de maturação nuclear de oócitos com o primeiro corpúsculo polar (CP) visível de pacientes inférteis sem e com endometriose. Comparar os resultados de Injeção Intracitoplasmática de espermatozóides (ICSI) entre os oócitos em telófase I e metáfase II, e entre aqueles com e sem fuso celular visível, nos grupos analisados. Metodologia: Estudo prospectivo e controlado com pacientes inférteis, submetidas à estimulação ovariana para realização de ICSI, selecionadas consecutivamente e divididas em dois grupos: Controle (fator tubário e/ou masculino) e Endometriose (subdividido em endometriose mínima e leve I/II versus moderada e severa III/IV). Os oócitos com extrusão do primeiro CP foram avaliados pela microscopia de polarização imediatamente antes da realização da ICSI e caracterizados quanto à presença/localização do fuso celular em relação ao primeiro CP e ao estágio de maturação nuclear (telófase I ou metáfase II). Foram analisados as taxas de fertilização, clivagem, número de embriões de boa qualidade no segundo (D2) e terceiro (D3) dia de desenvolvimento oriundos dos oócitos em telófase I versus metáfase II, e metáfase II com fuso visível versus sem fuso visível, nos grupos controle, endometriose, endometriose I/II e endometriose III/IV. Resultados: Foram analisados 441 oócitos, sendo 254 do grupo controle e 187 do grupo endometriose (115 do grupo endometriose I/II e 72 do grupo endometriose III/IV). Não observamos diferença significativa entre a percentagem de oócitos em metáfase II com fuso celular visível e não visível (88,6%, 91,3%, 88,2%, respectivamente, nos grupos controle, endometriose I/II e endometriose III/IV) e entre a percentagem de oócitos com fuso celular nas diferentes localizações nos grupos avaliados. Entre os oócitos aparentemente maduros, observamos um aumento significativo de oócitos em telófase I no grupo endometriose III/IV (5,6%) quando comparado ao grupo endometriose I/II (0%). Observamos uma tendência a menores taxas de fertilização dos oócitos injetados em telófase I quando comparados aos em metáfase II, nos grupos controle (p=0,08), endometriose (p=0,05) e endometriose III/IV (p=0,09). Comparando-se os oócitos com e sem fuso celular visível, não observamos diferença significativa nos resultados de ICSI entre os grupos analisados. Conclusão: Não observamos diferença significativa entre os grupos analisados quanto à visualização e localização do fuso celular em oócitos maturados in vivo com o primeiro CP visível. Todavia, observamos um aumento significativo de oócitos em telófase I nas portadoras de endometriose moderada e severa, sugerindo um retardo ou comprometimento na conclusão da meiose I. Considerando que os oócitos injetados em telófase I apresentam piores taxas de fertilização do que os injetados em metáfase II, este achado poderia justificar o comprometimento dos resultados de reprodução assistida em mulheres inférteis com endometriose moderada e severa, além de ser utilizado com ferramenta prognóstica pós-ICSI. / Introduction: Although it has been a controversial issue for decades, a deleterious role of endometriosis on assisted reproductive techniques (ART) outcomes is questioned, which may be related to oocyte quality. For a mature oocyte be prepared for fertilization is necessary that the meiotic spindle keeps its integrity and its function. Objectives: To compare the presence and localization of the meiotic spindle and the oocyte nuclear maturation with the visible first polar body of infertile patients with and without endometriosis. To compare ICSI outcomes between oocytes on telophase I and metaphase II, and the ones with and without visible meiotic spindle, on those two groups. Methodology: A prospective and controlled study with infertile patients who underwent ovarian stimulation for purposes of ICSI, selected consecutively and divided into two groups: control (tubal and/or male factor) and endometriosis (subdivided in minimum and mild stage I/II versus moderate and severe stage III/IV). The oocytes with the first polar body extruded (in vivo matured oocytes) were imaged using a polarization microscopy immediately before ICSI and characterized according to the presence and localization of meiotic spindle and its relation to the first polar body and the nuclear maturation stage (telophase I and metaphase II). We have analyzed the fertilization rates, clivage, number of good quality embryos on the second (D2) and third (D3) day of development from oocytes on telophase I versus the ones on metaphase II, and metaphase II visible spindle versus the non-visible ones, on the control groups, endometriosis, endometriosis stage I/II and endometriosis stage III/IV. Results: A total of 441 oocytes were analyzed, 254 oocytes form the control group and 187 from the endometriosis one (115 from endometriosis stage I/II and 72 from endometriosis stage III/IV). No significant differences between the percentage of metaphase II with visible and non-visible meiotic spindle were found (88,6%, 91,3%, and 88,2%, in the control, endometriosis I/II and endometriosis III/IV groups, respectively). Among the apparently matured oocytes, we have observed a significant increase of oocytes on telophase I on the endometriosis III/IV group (5,6%) when compared with the endometriosis I/II group (0%). We have observed a tendency to fewer fertilization rates from the injected oocytes on telophase I when compared with the ones on metaphase II, on the control group (p=0,08), endometriosis (p=0,05) and endometriosis III/IV group (p=0,09). When we compared oocytes with and without visible meiotic spindle, we found no significant difference on ICSI outcomes among the studied groups. Conclusions: We have found no significant difference among the studied groups regarding the visualization and localization of the meiotic spindle from in vivo matured oocytes with a visible first polar body. However, we have observed a significant increase on the number of oocytes on telophase I from patients with moderate and severe endometriosis, suggesting a delay or an impairment in the completion of meiosis I. Since the injected oocytes on telophase I present a worse fertilization rates than the ones injected on metaphase II, this finding could explain the impairment on the outcomes of ART in infertile women with moderate and severe endometriosis, besides it could be used as a prognosis tool after ICSI procedures.

TIF1γ est une protéine nucléaire de 1127 acides aminés possédant deux activités : une activité d'E3-ubiquitine ligase et des fonctions de régulateur transcriptionnel. TIF1γ exerce majoritairement ses fonctions dans les processus de développement embryonnaire et de différenciation cellulaire, notamment via son implication dans la voie de signalisation du TGFβ. Le rôle anti-tumoral de TIF1γ a été mis en évidence dans plusieurs modèles murins et son expression est diminuée dans de nombreuses tumeurs humaines de diverses origines tissulaires. Néanmoins, les mécanismes moléculaires et cellulaires par lesquels TIF1γ exerce ses fonctions oncosuppressives sont méconnus. Dans ces travaux, nous avons pu mettre en évidence le rôle inhibiteur de TIF1γ sur la transition épithélio-mésenchymateuse (EMT, Epithelial-to- Mesenchymal Transition) médiée par le TGFβ in vivo, permettant ainsi de limiter les propriétés agressives des cellules tumorales. De plus, nous avons décrit l'implication de TIF1γ dans la progression de la mitose et le point de contrôle du fuseau mitotique : les cellules n'exprimant plus TIF1γ présentent de nombreuses anomalies nucléaires ainsi qu'une forte aneuploïdie associée à une résistance aux agents ciblant les microtubules, molécules classiquement utilisées en chimiothérapie. De plus, nous avons pu corréler la faible expression de TIF1γ à une augmentation de l'instabilité chromosomique dans différentes tumeurs humaines. Ainsi, nos travaux ont permis de mettre en évidence le phénotype cellulaire induit par la perte de TIF1γ dans les cellules tumorales : instabilité chromosomique, résistance aux traitements chimiothérapeutiques et acquisition de propriétés invasives / TIF1γ / TRIM33 (Transcriptional Intermediary Factor 1γ / TRIpartite Motif-containing 33) is a 1,127 amino acids nuclear protein with two biochemical activities: an E3-ubiquitin ligase activity and transcriptional regulatory functions. TIF1γ is ubiquitously expressed in many organisms and exerts its functions mainly in the processes of embryonic development and cell differentiation, particularly through its involvement in the TGFβ signaling pathway. The oncosuppressive functions of TIF1γ have been demonstrated in several mouse models and its expression is reduced in many human tumors of various tissue origins. Nevertheless, the molecular and cellular mechanisms driving TIF1γ anti-tumoral activities are unknown. In this work, we highlight its inhibitory role on TGFβ-mediated EMT (Epithelial-to-Mesenchymal Transition) in vivo, thus limiting the aggressive properties of tumor cells. In addition, we describe TIF1γ involvement in mitotic progression and the Spindle Assembly Checkpoint (SAC): TIF1γ deleted cells display many nuclear abnormalities, aneuploidy and resistance to spindle microtubule-disrupting agents, which are drugs classically used in chemotherapeutic treatments. Finally, we correlated the low expression level of TIF1γ to an increased rate of chromosomal instability in different human tumors. Thus, our work has highlighted the tumor suppressor role of TIF1γ: its deletion in tumor cells induce chromosomal instability, resistance to chemotherapeutic treatments and acquisition of invasive properties

The master‘s thesis deals with the design of the spindle and tool magazine for multispindle machining centre.

The content of this diploma thesis is the design and construction of small vertical CNC milling machines. In the thesis are listed and machines that appear in today's production on the market. The components are designed for tools, for ball screw, linear guide. Parts are attached to the 3D models with vertical machine and drawings of the proposed machinery.

The aim of the diploma thesis is a milling head spindle heat treatment and production technology of this part. The introductory section of the thesis covers tasks of milling head spindle and required properties. Also includes overview of most-known types of heat and chemical treatment and milling head spindle production technology process proposal, which presents in more detail nitrocarburizing process called ARCOR V. Experimental part of the thesis gives consideration as well to the liquid salt bath nitrocarburizing application on different material samples and assessment of nitrocarburized material for this heat treatment process. The result of the thesis is spindle production technology process description with application of nitrocarburizing ARCOR V and also determination of suitability of selected materials for this surface treatment method and it’s practical applications.